Search results
Showing 421 to 435 of 2576 results for methods
Awaiting development Reference number: GID-TA11608 Expected publication date: TBC
Awaiting development Reference number: GID-TA11575 Expected publication date: TBC
Opicapone for adjunctive treatment of motor signs and symptoms in Parkinson's disease TS ID 11941
Awaiting development Reference number: GID-TA11481 Expected publication date: TBC
Xeomin (botulinum neurotoxin type A) for treating lower limb spasticity [TSID11902]
Awaiting development Reference number: GID-TA11417 Expected publication date: TBC
Awaiting development Reference number: GID-TA11549 Expected publication date: TBC
Awaiting development Reference number: GID-TA11507 Expected publication date: TBC
Dupilumab for treating eosinophilic oesophagitis in children 1 to 11 years [ID6492]
Awaiting development Reference number: GID-TA11383 Expected publication date: TBC
V940 with pembrolizumab for adjuvant treatment of resected high-risk stage 2 to 4 melanoma [ID6674]
Awaiting development Reference number: GID-TA11881 Expected publication date: TBC
Cosibelimab for treating advanced cutaneous squamous cell carcinoma [ID6663]
Awaiting development Reference number: GID-TA11883 Expected publication date: TBC
Awaiting development Reference number: GID-TA11706 Expected publication date: TBC
Awaiting development Reference number: GID-TA11653 Expected publication date: TBC
Awaiting development Reference number: GID-TA11641 Expected publication date: TBC
Obinutuzumab for treating serologically active extra-renal lupus [ID6670]
Awaiting development Reference number: GID-TA11886 Expected publication date: TBC
Semaglutide 7.2 mg single-dose device for managing overweight and obesity [ID6699]
Awaiting development Reference number: GID-TA11920 Expected publication date: TBC
This guideline covers how general dental practice teams can convey advice about oral hygiene and the use of fluoride. It also covers diet, smoking, smokeless tobacco and alcohol intake.